Hudson Bay Capital Management
FATE icon

Hudson Bay Capital Management’s Fate Therapeutics FATE Stock Holding History

Hudson Bay Capital Management’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.9K Buy
+25,160
New +$46.6K ﹤0.01% 1195
2024
Q2 		– Sell
-460,000
Closed -$3.38M – 830
2024
Q1 		$3.38M Buy
+460,000
New +$2.85M 0.02% 380
2023
Q1 		– Sell
-51,754
Closed -$522K – 898
2022
Q4 		$522K Buy
+51,754
New +$972K 0.01% 719

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Hudson Bay Capital Management's FATE Position: Q2 2026 in Review

Hudson Bay Capital Management opened a new position in Fate Therapeutics (FATE) in Q2 2026: 25,160 shares worth $67.9K. The stake represents ﹤0.01% of the portfolio and ranks #1195 among its holdings. This is a return to the name: Hudson Bay Capital Management previously reported a position in FATE as recently as Q1 2024.

Hudson Bay Capital Management first reported a position in FATE in Q4 2022 and has held it in 3 quarters since. The position peaked at $3.38M in Q1 2024. 156 funds tracked by Wall St. Rank hold FATE as of Q2 2026.

  • Hudson Bay Capital Management held 25,160 shares of Fate Therapeutics worth $67.9K as of Q2 2026.
  • Fate Therapeutics was a new Hudson Bay Capital Management position in Q2 2026.
  • Fate Therapeutics made up ﹤0.01% of Hudson Bay Capital Management's portfolio in Q2 2026, its #1195 holding.
  • Hudson Bay Capital Management first reported a position in Fate Therapeutics in Q4 2022 and has held it in 3 quarters since.
  • Hudson Bay Capital Management's Fate Therapeutics position peaked at $3.38M in Q1 2024.
  • 156 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.